A Study of Stapokibart Injection in Patients With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)
Clinical trial NCT07483268 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07483268
- Sponsor
- Chengdu Kangnuoxing Biopharma,Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-05-29
- Primary completion
- 2027-12-01
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.